2 - 2 |
Wrapping up 2016 Seijo BC |
5 - 5 |
Boron nitride converts propane to propene Jacoby M |
7 - 7 |
ACS journals enact across-the-board safety policy Kemsley J |
7 - 7 |
New tricks with aryl Grignards Halford B |
8 - 8 |
Solar device desalinates water efficiently Wilson E |
8 - 8 |
Getting red blood cells to carry drugs Borman S |
10 - 10 |
Easily made antireflective coatings for flexible surfaces Patel P |
10 - 10 |
Polymer reduces drug conjugate immune reactions Borman S |
10 - 11 |
Bitterness in wild cucumber, melon, and watermelon Everts S |
11 - 11 |
Layered structure improves patch conductivity Arnaud C |
11 - 11 |
Coupling phenols and allylic alcohols Halford B |
11 - 11 |
Bismuth provides catalytic surprises Ritter S |
12 - 12 |
Japanese firms eye shale gas revolution Tremblay JF |
12 - 12 |
Companies invest in aquaculture ingredients Scott A |
13 - 13 |
Group grades retailers on safer chemicals in products Bomgardner M |
13 - 13 |
Patheon acquires a Roche facility Mullin R |
13 - 13 |
Axial debuts to link neuroscience and gut Thayer A |
14 - 14 |
Pfizer invests in US, eases up in Ireland Scott A |
14 - 14 |
Evonik clinches deal for biobased methionine Mccoy M |
14 - 14 |
Waters, Bruker back phenotype network Reisch M |
14 - 14 |
Linde, Praxair merger talks back on again Reisch M |
14 - 14 |
Adidas kicks off spider silk shoes Scott A |
14 - 14 |
CEFIC bemoans EU disclosure ruling Scott A |
14 - 14 |
Drug firm may have used tainted heparin Tremblay F |
14 - 15 |
Givaudan expands in Singapore Reisch M |
15 - 15 |
J&J negotiates to buy Actelion Thayer A |
15 - 15 |
Arrowhead sheds programs, staff Jarvis L |
15 - 15 |
Sanofi gets Warp Drive aminoglycosides Jarvis L |
15 - 15 |
Medlmmune, Abpro form research venture Mullin R |
16 - 16 |
EPA flexes muscle under new chemical safety law Erickson B |
16 - 16 |
Groups ask Trump to focus on science Widener A |
17 - 17 |
Canada targets triclosan in wastewater Erickson B |
17 - 17 |
UK to ratify single EU patent system Hess G |
17 - 17 |
CSB nominee has strong industry ties Johnson J |
17 - 17 |
Model predicts decline in Oklahoma temblors Morrison J |
18 - 21 |
Cautious optimism for an HIV vaccine Cross R |
22 - 23 |
Growing pains in Cambridge, England Scott A |
24 - 25 |
PPG counts on chemistry to give it an edge Reisch MS |
26 - 27 |
C&EN talks with Kumudini Meepagala, mosquito repellent researcher Pelley J |
28 - 29 |
Industrial strength education Davenport M |
31 - 32 |
Perspectives: When are industries judged fairly? Fischhoff B |
36 - 36 |
PHARMA YEAR IN REVIEW 2016 [Anonymous] |
37 - 37 |
Behind the EpiPen Mullin R |
38 - 38 |
Zika response in full gear Jarvis L |
38 - 38 |
AbbVie's Humira held onto top spot despite biosimilar threat Thayer A |
40 - 40 |
After the upset Mullin R |
41 - 41 |
Pharmaceutical firms saw mixed year in 2016 Thayer A |
41 - 41 |
Eteplirsen controversy hit FDA Jarvis L |
42 - 42 |
Biotech firms managed to go public in rocky year Thayer A |
42 - 42 |
Moonshot mania Jarvis L |
43 - 43 |
Breakup of Pfizer and Allergan shaped the year Thayer A |
44 - 44 |
A focus on data Tremblay JF |
45 - 45 |
Why ACS approval matters for a chemistry program Wenzel TJ, Kosbar L |
46 - 49 |
Celebrating National Chemistry Week Wang LD |
50 - 50 |
Looking backward to move forward [Anonymous] |
56 - 56 |
JLo jumps on the CRISPR bandwagon [Anonymous] |
56 - 56 |
"The Chemist" baffles with its use of science [Anonymous] |